CClinicalTrials.gg
Not yet recruitingNCT07847801EGA-LHUpdated Sep 29, 2026

Epidural Versus General Anesthesia for Laparoscopic Hysterectomy

An interventional study of epidural anesthesia and General Anesthesia (GA) in Anesthesia for Laparoscopic Hysterectomy, sponsored by Sabiha Başarı. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Sabiha Başarı · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

This randomized controlled study will compare epidural anesthesia with general anesthesia in women undergoing elective laparoscopic hysterectomy. A total of 70 participants will be randomly assigned to receive either epidural anesthesia or general anesthesia.

The main aim of the study is to determine whether the type of anesthesia affects respiratory function after surgery. Respiratory function will primarily be assessed using peak expiratory flow rate (PEFR) before surgery and at 2, 6, and 24 hours after surgery.

The study will also compare postoperative pain, opioid consumption, respiratory and hemodynamic parameters, recovery, mobilization, and other perioperative outcomes between the two groups.

The researchers aim to determine whether epidural anesthesia may provide an alternative anesthetic approach for selected patients undergoing laparoscopic hysterectomy while maintaining spontaneous breathing.

Read the detailed description

This is a prospective, single-center, randomized, controlled, parallel-group study involving 70 adult women scheduled for elective laparoscopic total hysterectomy.

Participants will be randomly allocated in a 1:1 ratio to an epidural anesthesia group or a general anesthesia group. In the epidural anesthesia group, anesthesia will be provided through a lumbar epidural catheter, with spontaneous ventilation maintained. Sedation will be provided as required. In the general anesthesia group, anesthesia will be induced intravenously, followed by endotracheal intubation and controlled mechanical ventilation.

Respiratory function will be evaluated using peak expiratory flow rate (PEFR) before surgery and at 2, 6, and 24 hours after surgery. Postoperative pain scores, opioid consumption, respiratory and hemodynamic parameters, recovery characteristics, mobilization, and perioperative adverse events will also be evaluated.

Participants in the epidural anesthesia group may be converted to general anesthesia if the epidural block is inadequate, the participant cannot tolerate the procedure, or conversion is considered clinically necessary.

02

Conditions studied

  • Anesthesia for Laparoscopic Hysterectomy

Browse trials for

Keywords

  • Epidural Anesthesia
  • General Anesthesia
  • Laparoscopic Hysterectomy
  • Postoperative Respiratory Function
  • Peak Expiratory Flow Rate
  • Postoperative Pain
  • Opioid Consumption
03

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female patients aged 18-70 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body mass index (BMI) ≤30 kg/m²
  • Scheduled for elective laparoscopic total hysterectomy
  • Willing and able to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Contraindication to neuraxial anesthesia
  • Severe cardiopulmonary disease
  • BMI >30 kg/m²
  • Pre-existing neurological disorder
  • Inability to cooperate with the study procedures
  • Refusal to participate in the study
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Epidural Anesthesia

    Participants assigned to this arm will receive epidural anesthesia via a lumbar epidural catheter. An initial dose of 10 mL of 0.5% bupivacaine with 50 mcg fentanyl will be administered, followed by incremental doses of 2-3 mL of 0.5% bupivacaine every 5 minutes as required to achieve a T4 sensory block, up to approximately 20 mL. Spontaneous ventilation will be maintained. Dexmedetomidine will be administered at 0.2 mcg/kg/h for sedation. Conversion to general anesthesia will be performed if the epidural block is inadequate, the participant cannot tolerate the procedure, or conversion is clinically required.

    Procedure: epidural anesthesia

  • Active comparator
    General Anesthesia

    Participants assigned to this arm will receive standard general anesthesia. Anesthesia will be induced with propofol 2-2.5 mg/kg, fentanyl 1-2 mcg/kg, and rocuronium 0.6 mg/kg, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation, with end-tidal carbon dioxide maintained between 35 and 40 mmHg.

    Procedure: General Anesthesia (GA)

Interventions

  • Procedureepidural anesthesia

    pidural anesthesia will be administered via a lumbar epidural catheter using 0.5% bupivacaine and fentanyl. Incremental epidural doses will be administered to achieve an adequate sensory block. Spontaneous ventilation will be maintained, and dexmedetomidine will be used for sedation.

  • ProcedureGeneral Anesthesia (GA)

    General anesthesia will be induced with intravenous propofol, fentanyl, and rocuronium, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation.

05

What researchers measure

Primary outcomes

  1. Change in Peak Expiratory Flow Rate (PEFR)

    Peak expiratory flow rate (PEFR), measured in liters per minute (L/min), will be assessed before surgery and at 2, 6, and 24 hours after surgery. The change in PEFR from the preoperative baseline will be compared between the epidural anesthesia and general anesthesia groups

    Time frame: Preoperative baseline and 2, 6, and 24 hours after surgery

06

Study locations

1 site
07

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data that underlie the results reported in the published article may be shared upon reasonable request to the corresponding author.

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07847801
Lead sponsor
Sabiha Başarı
Responsible party
Sabiha Başarı (Anaesthesiology and Intensive Care Specialist, Kutahya City Hospital) — Sponsor-investigator
First posted
Sep 29, 2026
Start date
Oct 22, 2026 (estimated)
Primary completion
Oct 22, 2027 (estimated)
Completion
Oct 22, 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Sabiha Başarı, MD
Contact
sabihabasari0@gmail.com
+905446616686
Sabiha Başarı, MD
principal investigator · Kutahya City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion